The Global MRD (Minimal Residual Disease) Testing Market is predicted to grow at a CAGR of 15% over the forecast period, 2021-2027. The minimal residual disease test is useful for identifying traces of leukemia cells during and after cancer treatment. The different treatments used during the onset of disease can be tested with minimal residual […]
